Laurus Labs Ltd.

₹1,945

8 (0.4%)

LAURUSLABS Share Price

Pharmaceuticals & Biotechnology

As on September 10, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,04,366 Cr

P/E Ratio118.14

Dividend Yield0.05 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,909.12	Bullish
10-DMA	1,899.32	Bullish
20-DMA	1,865.83	Bullish
50-DMA	1,749.52	Bullish
100-DMA	1,537.65	Bullish
200-DMA	1,284.86	Bullish

Historical Performance

1 Year

117%

3 Years

374.1%

5 Years

196.5%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	68,129	55,540	50,408	60,405	49,356
Total Expenditure	50,352	44,987	42,633	44,484	35,131
Other Income	550	751	263	60	153
Operating Profit	18,327	11,304	8,038	15,982	14,377
Interest	1,707	2,160	1,829	1,652	1,024
Depreciation	4,800	4,301	3,846	3,241	2,515
Profit Before Tax	11,819	4,843	2,364	11,089	10,838
Consolidated Net Profit	8,888	3,583	1,577	7,845	8,275
Adjusted EPS	16	7	3	15	15

Compounded Sales Growth

10 Years:30.8

5 Years:7.2

3 Years:2.4

TTM:4.2

Compounded Profit Growth

10 Years:46.1

5 Years:-2

3 Years:2.5

TTM:19.9

Stock Price CAGR

10 Years:N/A

5 Years:24.3

3 Years:68.4

TTM:117.3

Return on Equity

10 Years:3.6

5 Years:15.4

3 Years:2.9

last year:16.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	1,080	1,078	1,078	1,077	1,075
Total Reserves	51,671	43,387	39,817	39,177	32,346
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	14,444	11,933	11,592	11,795	9,280
Other Current Liabilities	7,985	7,797	6,107	6,408	8,397
Short Term Borrowings	14,926	17,150	13,893	9,958	9,107
Total Liabilities	1,05,112	93,356	83,870	76,604	69,680
Capital Work in Progress	7,733	4,584	4,228	5,508	8,132
Long Term Loans & Advances	2,013	1,634	835	1,606	841
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	1,841	2,071	1,472	1,089	1,345
Total Current Assets	48,292	43,323	38,350	34,617	33,446
Total Assets	1,05,112	93,356	83,870	76,604	69,680
Adjusted Book Value	98	82	76	75	62

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 118.14, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 68.4%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹18327 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹68129 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2171728.5

No. of Shares: 1117 (Approx)

Performance:117.2%

1171728.5

NIFTY Performance: -6.1%

1 day Top Gainers